Clinical trial Recruiting at 1 site Interventional Ages 18 to 60 Women only

Pain during IUS insertion: traditional method vs ultrasound-guided (TAS) technique

Official title: The PAINLESS Study: Pain Associated wIth traditioNal Versus uLtrasound guidEd iuS (Intra Uterine System) inSertion

Run by University Hospital, Ghent · NCT07315646 · Data updated 2026-11-12

This study tests whether using a transabdominal ultrasound (TAS) guided method reduces pain for women getting an intrauterine system for contraception or treatment.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexWomen only
Enrollment50 (estimated)
SponsorUniversity Hospital, Ghent
Academic / other
Locations1 site (Ghent)
StatusRecruiting
StartedFebruary 11, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedJuly 30, 2026
Trial IDNCT07315646 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Dutch-speaking women aged 18–60 who wish to have an IUS and meet safety criteria with no history of difficult IUS placement or cervical stenosis.

Probably not a fit

Women with contraindications to IUS or those experiencing factors that make ultrasound guidance ineffective may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares the standard cervical technique for inserting an intrauterine system with a transabdominal ultrasound guided approach. The TAS method aims to minimize pain during insertion by guiding instrument placement without relying on the traditional traction method. Eligible participants are Dutch-speaking women aged 18 to 60 who wish to use an IUS for contraception, abnormal uterine bleeding, or menopausal symptoms and who meet safety criteria. The study is led by University Hospital Ghent with collaboration from Imelda Hospital and takes place at Ghent University Hospital. No phase information is provided for this trial.

Why it matters

Potential benefit: If successful, the TAS technique could reduce pain during IUS insertion and improve comfort and uptake of LARC methods.

How similar studies have gone: Prior data suggest ultrasound-guided approaches can influence pain experience in similar procedures, but this exact TAS approach for IUS insertion is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women between18 years and 60 years (at the time of signing the ICF)
* Who wish to have an IUS (Kyleena/Mirena) for reasons of family planning, conservative treatment for abnormal uterine bleeding or as part of hormonal treatment for menopausal symptoms
* Dutch-speaking subjects

Exclusion Criteria:

* History of difficult IUS placement
* Known cervical stenosis
* Asherman's syndrome
* Standard contraindications to an IUS (eg breast cancer, recent deep vein thrombosis, anatomical uterine abnormalities, pregnancy, acute PID, cervicitis, vaginitis or any lower genital tract infection, cervical or endometrial malignancy, history of septic abortion or postpartum endometritis in the last 3 months,.. )
* Current pelvic inflammatory disease
* Pregnancy
* Trophoblastic disease
* Known cervical or endometrial carcinoma
* Patients who have the profession of midwife, nurse or doctor.

Where it's running

  • Ghent University Hospital
    Ghent, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.